| CAS ID: | 90566-53-3 |
| Molecular Formula: | C22H27F3O4S |
| Molecular Weight: | 444.5 g/mol |
| Monoisotopic Mass: | 444.1582 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | Fluticasone |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C22H27F3O4S/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)30-10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1 | See All |
| InChI Key: | MGNNYOODZCAHBA-GQKYHHCASA-N | |
| Smiles: | C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00220259 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | September 22, 2005 | Last Verified | November 8, 2005 |
| Sponsor | Royal Brompton & Harefield NHS Foundation Trust | ||
| PubChem: | 5311101 |
| ChEMBL: | CHEMBL1201396 |